nach oben

Pharmaceutical Medicine

Erschienen in:

01.05.2021 | Meeting Report

73rd Annual Meeting of the American Academy of Neurology (AAN 2021): 17–22 April 2021

verfasst von: Sue Pochon

Erschienen in: Pharmaceutical Medicine | Ausgabe 3/2021

Einloggen, um Zugang zu erhalten

Excerpt

For the second year running, as a result of the COVID-19 pandemic, the Annual Meeting of the American Academy of Neurology (AAN) was held virtually. The meeting was attended by over 13,000 people from nearly 115 countries, with the vast majority attending live. …

Paganoni S, Macklin EA, Hendrix S, et al. Trial of sodium phenylbutyrate–taurursodiol for amyotrophic lateral sclerosis. N Engl J Med. 2020;383:919–30.CrossRef

Paganoni S, Hendrix S, Dickson SP, et al. Long-term survival of participants in the CENTAUR trial of sodium phenylbutyrate-taurursodiol in amyotrophic lateral sclerosis. Muscle Nerve. 2021;63:31–9.CrossRef

Paganoni S, Hendrix S, Dickson S, et al. Long-term survival of participants in the CENTAUR trial of AMX0035 for ALS [abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Paganoni S, Macklin EA, Hendrix S, et al. Lower long-term risk of death or permanent ventilation and first hospitalization among participants with ALS receiving AMX0035 in the CENTAUR trial[abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Hill MD, Goyal M, Menon BK, et al. Efficacy and safety of nerinetide for the treatment of acute ischaemic stroke (ESCAPE-NA1): a multicentre, double-blind, randomised controlled trial. Lancet. 2020;395(10227):878–87.CrossRef

Ailani J, Lipton R, Goadsby PJ, et al. Atogepant Significantly Reduces Mean Monthly Migraine Days in the Phase 3 Trial (ADVANCE) for the Preventive Treatment of Migraine [abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Dauvilliers Y, Arnulf I, Foldvary-Schaefer N, at el. Efficacy and safety of lower-sodium oxybate in a phase 3, placebo-controlled, double-blind, randomized withdrawal study in adult participants with idiopathic hypersomnia [abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Howard J, Bril V, Vu T, et al. Efficacy, safety, and tolerability of efgartigimod in patients with generalized myasthenia gravis: analysis of the phase 3 ADAPT Study [abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Kushlaf H, Attarian S, Borges JL, et al. Efficacy and safety results of the avalglucosidase alfa phase 3 COMET trial in late-onset Pompe disease patients [abstract]. 2021 Annual Meeting of the American Academy of Neurology (AAN). 17–22 April; Virtual. https://index.mirasmart.com/AAN2021/index.php. Accessed 5 May 2021.

Titel: 73rd Annual Meeting of the American Academy of Neurology (AAN 2021): 17–22 April 2021
verfasst von: Sue Pochon
Publikationsdatum: 01.05.2021
Verlag: Springer International Publishing
Erschienen in: Pharmaceutical Medicine / Ausgabe 3/2021
Print ISSN: 1178-2595
Elektronische ISSN: 1179-1993
DOI: https://doi.org/10.1007/s40290-021-00391-y

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

73rd Annual Meeting of the American Academy of Neurology (AAN 2021): 17–22 April 2021

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2021

Major Pharmaceutical Conferences and Courses: August to September 2021

The Critical Need to Build a European Governance Model for Online Access to Medical Information Services: A Position Paper

The Term “Juvenile Idiopathic Arthritis (JIA)” is Misleading. It Will not be Sufficient to Just Replace this Term

The Epidemic of Substandard and Falsified Medications in Iraq: Evaluating the Effectiveness of National Pharmacovigilance Alerts to Community Pharmacies

The Utility of Patient Engagement in Drug Research and Development

Symptoms of Medication Withdrawal in Parkinson’s Disease: Considerations for Informed Consent in Patient-Oriented Research